NCT00808808

Assessing Choice in the Employer Setting (ACES) Study

Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 4,411 (actual)
• Sponsor: MedImmune LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

Detailed description

The primary objective is to determine, among adults in the 18-49 year old population and in the total population, the effects of offering a choice of FluMist or TIV with and without enhanced advertisement/added incentive on the overall influenza vaccination rates in the employer setting when compared to a control group.

Conditions

• Healthy

Interventions

Type	Name	Description
BIOLOGICAL	Choice of TIV or FluMist with baseline advertisement	An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist
OTHER	Choice of TIV or FluMist with enhanced advertisement and incentives	An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination
BIOLOGICAL	Control - Usual care offering TIV only with baseline advertisement	A control arm of usual care offering TIV with baseline advertisement

Timeline

• Start date: 2008-09-01
• Primary completion: 2008-11-01
• Completion: 2008-12-01
• First posted: 2008-12-16
• Last updated: 2013-11-20
• Results posted: 2012-09-13

Locations

47 sites across 1 country: United States